Authors: Madison Muller August 25, 2022 Bloomberg Almost 40% of people hospitalized in the US with the Covid subvariant that circulated this spring were vaccinated and boosted, highlighting how new strains have mutated to more readily escape the immunity offered by current shots. The findings from scientists at the US Centers for Disease Control and […]
The Covid-19 antiviral drug can leave a foul taste. The afflicted are scouring for remedies online. Authors: Alex Janin Aug. 16, 2022 Wall Street Journal Jeanette Witten recently rummaged through her pantry for Red Hots, the cinnamon-flavored candy. The 56-year-old in Montclair, N.J., was looking for a reprieve from a persistent residual taste—“like your mouth is […]
Authors: Mimi Nguyen Ly June 16, 2022 The Epoch Times Paxlovid, a Pfizer COVID-19 pill, is seen manufactured in Ascoli, Italy, in this undated photo obtained by Reuters on Nov. 16, 2021. (Pfizer/Handout via Reuters) Pfizer has announced it will stop enrollment in a clinical trial for Paxlovid—its COVID-19 antiviral pill—for standard-risk COVID-19 patients after the latest results suggested […]
Authors: Jack Phillips via The Epoch Times, JUN 01, 2022 Centers for Disease Control and Prevention Director Rochelle Walensky warned that Pfizer’s COVID-19 pill Paxlovid can lead to a rebound in symptoms. “If you take Paxlovid, you might get symptoms again,” Walensky told CBS News on Tuesday. “We haven’t yet seen anybody who has returned with symptoms needing to go […]
Authors: Benjamin Ryan Published April 29, 2022 NBC Health Pfizer’s antiviral pills are highly effective at keeping people with Covid out of the hospital, but there are growing reports that, in rare cases, patients treated for the coronavirus with Paxlovid can experience a second round of the disease shortly after recovering. Infectious disease experts stress that cases […]
Authors: MATTHEW PERRONE May 9, 2022 AP NEWS As more doctors prescribe Pfizer’s powerful COVID-19 pill, new questions are emerging about its performance, including why a small number of patients appear to relapse after taking the drug. Paxlovid has become the go-to option against COVID-19 because of its at-home convenience and impressive results in heading […]
Authors: Zachary Stieber May 8, 2022 The U.S. Food and Drug Administration (FDA) is investigating reports of relapses among people who took Pfizer’s COVID-19 pill. The FDA “is evaluating the reports of viral load rebound after completing paxlovid treatment and will share recommendations if appropriate,” an agency spokesperson told The Epoch Times in an email. […]
Paxlovid, authorized to treat high-risk people early in infection, didn’t meaningfully reduce illness in exposed adults Authors: Jared S. Hopkins Apr. 29, 2022 The Wall Street Journal The Covid-19 pill from Pfizer Inc. failed to prevent symptomatic infections in adults who had been exposed to the pandemic virus, a late-stage study found. Pfizer said Friday that the […]
Authors: Carolyn Y. Johnson April 27, 2022 The Washington Post Shortly after he served on a jury in March, Gregg Crumley developed a sore throat and congestion. The retired molecular biologist took a rapid test on a Saturday and saw a dark, thick line materialize — “wildly positive” for the coronavirus. Crumley, 71, contacted his […]
